AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32130065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention directed toward the neck
Number of subjects: 80
Study 32130065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention directed toward the mouth
Number of subjects: 80
Study 32130065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention within the eye‐nose‐cheek triangle
Number of subjects: 80
Study 32130065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention within the eye‐nose‐mouth triangle
Number of subjects: 80
Study 34806331 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone soft capsule under fasting conditions
Number of subjects: 96
Study 34806331 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone soft capsule under fed conditions (high-fat meal, 890 kcal)
Number of subjects: 96
Study 33271398 — intervention group
Group type: EXPERIMENTAL
Intervention: Violent game player
Number of subjects: 192
Study 33271398 — intervention group
Group type: COMPARATOR
Intervention: Violent game observer
Number of subjects: 192
Study 33271398 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral game player
Number of subjects: 192
Study 33271398 — intervention group
Group type: COMPARATOR
Intervention: Neutral game observer
Number of subjects: 192
Study 35779136 — intervention group
Group type: EXPERIMENTAL
Intervention: High diet (20% crude protein, 67.9% total digestible nutrients)
Number of subjects: 9
Study 35779136 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium diet (17% crude protein, 66% total digestible nutrients)
Number of subjects: 9
Study 35779136 — intervention group
Group type: EXPERIMENTAL
Intervention: Low diet (12.2% crude protein, 62.9% total digestible nutrients)
Number of subjects: 9
Study 34626515 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib (Btz) in combination with melphalan and prednisolone (MPB)
Number of subjects: 82
Study 34626515 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-B*40:06
Number of subjects: 82
Study 34626515 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-B*40:06 and HLA-DRB1*12:01
Number of subjects: 82
Study 34626515 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-DRB1*08:02
Number of subjects: 82
Study 34626515 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-DQB1*03:02, HLA-DQB1*05:01, and HLA-DRB1*01:01
Number of subjects: 82
Study 35121396 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic‐RPA group M1a (no co‐existing liver‐bone metastases)
Number of subjects: 183
Study 35121396 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic‐RPA group M1b (co‐existing liver‐bone metastases)
Number of subjects: 183
Study 33947873 — intervention group
Group type: EXPERIMENTAL
Intervention: BD‐II patients (n=149)
Number of subjects: 371
Study 33947873 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite probability score based on five proteins in training group
Number of subjects: 371
Study 33947873 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite probability score based on five proteins in testing group
Number of subjects: 371
Study 33066974 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRI exposure (fluoxetine, sertraline, escitalopram/citalopram)
Number of subjects: 1228
Study 33066974 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine exposure
Number of subjects: 1228
Study 33066974 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRI exposure
Number of subjects: 1228
Study 36194057 — intervention group
Group type: EXPERIMENTAL
Intervention: AlloDerm
Number of subjects: 128
Study 36194057 — intervention group
Group type: COMPARATOR
Intervention: DermaMatrix
Number of subjects: 128
Study 36194057 — intervention group
Group type: EXPERIMENTAL
Intervention: AlloDerm and DermaMatrix
Number of subjects: 128
Study 34043621 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosquito Exposure Index (MEI) measured by ELISA for anti-Aedes saliva antibodies
Number of subjects: 360
Study 34043621 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosquito Exposure Index (MEI) for indoor Aedes densities
Number of subjects: 360
Study 34043621 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual characteristics influencing MEI
Number of subjects: 360
Study 34043621 — intervention group
Group type: COMPARATOR
Intervention: Correlation between MEI and DENV-infected Aedes
Number of subjects: 360
Study 32236147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Walking (NW) training 3 times a week for 6 weeks
Number of subjects: 18
Study 32236147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Walking (NW) training
Number of subjects: 18
Study 32236147 — intervention group
Group type: COMPARATOR
Intervention: Nordic Walking (NW)
Number of subjects: 18
Study 35933340 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 35933340 — intervention group
Group type: EXPERIMENTAL
Intervention: Response-adaptive randomisation
Number of subjects: 0
Study 33118433 — intervention group
Group type: EXPERIMENTAL
Intervention: TEVAR with a bare stent
Number of subjects: 84
Study 33118433 — intervention group
Group type: COMPARATOR
Intervention: TEVAR only
Number of subjects: 84
Study 32182219 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 infusion
Number of subjects: 18
Study 36429728 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive sandbag exercise training (0.5 kg to 1 kg over 12 weeks)
Number of subjects: 40
Study 34170841 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular Closure Devices (VCDs)
Number of subjects: 604
Study 34170841 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular VCD
Number of subjects: 604
Study 32297352 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus 2-weekly home end-of-life and palliative care coaching by experienced community nurses
Number of subjects: 0
Study 32297352 — intervention group
Group type: COMPARATOR
Intervention: Standard care through their hospital or outpatient clinics
Number of subjects: 0
Study 35098823 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii-Fit
Number of subjects: 68
Study 35098823 — intervention group
Group type: EXPERIMENTAL
Intervention: Xbox Kinect
Number of subjects: 68
Study 35098823 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 68
Study 32818304 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracotomy
Number of subjects: 202
Study 32818304 — intervention group
Group type: COMPARATOR
Intervention: Thoracoscopy
Number of subjects: 202
Study 32833022 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking initiation (genetic determinants)
Number of subjects: 0
Study 32833022 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased smoking risk (2-fold)
Number of subjects: 0
Study 32833022 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI as a mediator
Number of subjects: 0
Study 32833022 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking behavior
Number of subjects: 0
Study 32833022 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking behavior (MVP data)
Number of subjects: 0
Study 36373571 — intervention group
Group type: EXPERIMENTAL
Intervention: man therapy (MT)
Number of subjects: 554
Study 36373571 — intervention group
Group type: COMPARATOR
Intervention: Healthy Men Michigan (HMM)
Number of subjects: 554
Study 34007070 — intervention group
Group type: EXPERIMENTAL
Intervention: CoVLP + AS03
Number of subjects: 180
Study 34007070 — intervention group
Group type: EXPERIMENTAL
Intervention: CoVLP + CpG1018
Number of subjects: 180
Study 34007070 — intervention group
Group type: COMPARATOR
Intervention: CoVLP (3.75 μg, 7.5 μg, and 15 μg)
Number of subjects: 180
Study 34007070 — intervention group
Group type: EXPERIMENTAL
Intervention: CoVLP
Number of subjects: 180
Study 32568399 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram oxalate (n = 162)
Number of subjects: 518
Study 32568399 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride (n = 176)
Number of subjects: 518
Study 32568399 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release venlafaxine hydrochloride (n = 180)
Number of subjects: 518
Study 32568399 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model using EEG and baseline symptom features
Number of subjects: 518
Study 34902651 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study 34902651 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics
Number of subjects: 0
Study 35535982 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine analysis of resting Doppler waveform using deep neural networks
Number of subjects: 3432
Study 35535982 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine analysis of resting Doppler waveform using deep neural networks (validation dataset)
Number of subjects: 3432
Study 33386332 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of 9vHPV vaccine (0, 6 regimen)
Number of subjects: 1150
Study 33386332 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of 9vHPV vaccine (0, 12 regimen)
Number of subjects: 1150
Study 33386332 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of 9vHPV vaccine (0, 2, 6 regimen)
Number of subjects: 1150
Study 32269109 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambler therapy
Number of subjects: 22
Study 32269109 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 22
Study 33636356 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Saline Solution (NSS)
Number of subjects: 540
Study 33636356 — intervention group
Group type: COMPARATOR
Intervention: Savlon Solution
Number of subjects: 540
Study 35575284 — intervention group
Group type: EXPERIMENTAL
Intervention: Hochuekkito administration
Number of subjects: 42
Study 35575284 — intervention group
Group type: COMPARATOR
Intervention: Control (non-hochuekkito administration)
Number of subjects: 42
Study 33724513 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental arm (specific treatment not detailed)
Number of subjects: 0
Study 33724513 — intervention group
Group type: COMPARATOR
Intervention: Standard of care arm
Number of subjects: 0
Study 32259266 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% aqueous chlorhexidine
Number of subjects: 7820
Study 32259266 — intervention group
Group type: COMPARATOR
Intervention: 10% povidone-iodine
Number of subjects: 7820
Study 32259266 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine in 70% isopropyl alcohol
Number of subjects: 7820
Study 32259266 — intervention group
Group type: COMPARATOR
Intervention: 0.7% iodine povacrylex in 74% isopropyl alcohol
Number of subjects: 7820
Study 32259266 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 7820
Study 36370817 — intervention group
Group type: COMPARATOR
Intervention: Half-occupied cabin
Number of subjects: 559
Study 36370817 — intervention group
Group type: COMPARATOR
Intervention: Fully occupied cabin
Number of subjects: 559
Study 33253833 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE) 80 mg every 2 weeks
Number of subjects: 1346
Study 33253833 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE) 80 mg every 4 weeks
Number of subjects: 1346
Study 33253833 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 1346
Study 32127061 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR 677TT genotype in male smokers
Number of subjects: 788
Study 32127061 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR 677TT genotype in nonsmokers
Number of subjects: 788
Study 32127061 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants >50 years with MTHFR 677TT genotype
Number of subjects: 788
Study 32127061 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants in the 3rd tHcy tertile
Number of subjects: 788
Study 32127061 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants >50 years with EGRAC
Number of subjects: 788
Study 32127061 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately elevated tHcy and MTHFR 677CT genotype
Number of subjects: 788
Study 36307361 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin A (BTA) - 50 units injected twice, 3 months apart
Number of subjects: 75
Study 34169543 — intervention group
Group type: EXPERIMENTAL
Intervention: AUC estimated from trough-only data using derived volume of distribution (Vd) equation: Vd (L) = 0.29(age) + 0.33(total BW in kg) + 11
Number of subjects: 4343
Study 34169543 — intervention group
Group type: COMPARATOR
Intervention: Other general adult Vd models
Number of subjects: 4343
Study 32792425 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) rapid test‐based prediction rule
Number of subjects: 7245
Study 32792425 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 7245
Study 36066588 — intervention group
Group type: EXPERIMENTAL
Intervention: Introspective writing task (IG)
Number of subjects: 29
Study 36066588 — intervention group
Group type: COMPARATOR
Intervention: Not-introspective writing task (CG)
Number of subjects: 29
Study 34706949 — intervention group
Group type: EXPERIMENTAL
Intervention: Implanted CRT defibrillator with AV delay fixed at 120 ms
Number of subjects: 741
Study 34706949 — intervention group
Group type: EXPERIMENTAL
Intervention: Implanted CRT defibrillator with echocardiography-determined AV delay
Number of subjects: 741
Study 34706949 — intervention group
Group type: EXPERIMENTAL
Intervention: Implanted CRT defibrillator with SmartDelay algorithm-programmed AV delay
Number of subjects: 741
Study 34706949 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall CRT response for women versus men
Number of subjects: 741
Study 34706949 — intervention group
Group type: EXPERIMENTAL
Intervention: Average treatment effect of CRT response
Number of subjects: 741
Study 34706949 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression results after removing colliders
Number of subjects: 741
Study 32628039 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary microsampling of 15 μl whole blood from fingersticks or heelsticks in a mebendazole study
Number of subjects: 0
Study 32628039 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary microsampling of 15 μl whole blood from fingersticks or heelsticks in a respiratory syncytial virus drug study
Number of subjects: 0
Study 35075097 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted processed honey
Number of subjects: 28
Study 35075097 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 28
Study 33888233 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip treatment
Number of subjects: 250
Study 35803625 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher oxygen saturation limit (≥95%)
Number of subjects: 198
Study 35803625 — intervention group
Group type: COMPARATOR
Intervention: Lower oxygen saturation limit (≥90%)
Number of subjects: 198
Study 34861685 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulox therapy twice weekly
Number of subjects: 79
Study 34861685 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (once-weekly podiatric medical clinic visits)
Number of subjects: 79
Study 35837815 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Support Intervention (CSI)
Number of subjects: 480
Study 35837815 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 480
Study 32574138 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination coverage for BCG, DTP, MMR, and HepB
Number of subjects: 3600
Study 32574138 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban area vaccination uptake
Number of subjects: 3600
Study 32574138 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver concerns for MMR vaccine
Number of subjects: 3600
Study 32574138 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall vaccination status
Number of subjects: 3600
Study 32574138 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustainability in supply and schedule
Number of subjects: 3600
Study 32418011 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte- and platelet-rich fibrin (LPRF)
Number of subjects: 44
Study 32418011 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-Gide® (BG)
Number of subjects: 44
Study 33950263 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned Pain Modulation (CPM) efficiency
Number of subjects: 39
Study 32718898 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfieri technique
Number of subjects: 48
Study 32718898 — intervention group
Group type: COMPARATOR
Intervention: Cutting technique
Number of subjects: 48
Study 34766584 — intervention group
Group type: EXPERIMENTAL
Intervention: ABM + Normal intervention
Number of subjects: 43
Study 34766584 — intervention group
Group type: COMPARATOR
Intervention: Normal intervention only
Number of subjects: 43
Study 35982101 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound group
Number of subjects: 90
Study 35982101 — intervention group
Group type: COMPARATOR
Intervention: Experience group
Number of subjects: 90
Study 35982101 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group
Number of subjects: 90
Study 34175675 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil (FTD/TPI)
Number of subjects: 511
Study 34615511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro‐Argin™
Number of subjects: 140
Study 34615511 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% strontium acetate
Number of subjects: 140
Study 34615511 — intervention group
Group type: EXPERIMENTAL
Intervention: FCPS
Number of subjects: 140
Study 34615511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride-based OTC dentifrices
Number of subjects: 140
Study 32400227 — intervention group
Group type: EXPERIMENTAL
Intervention: No past month drug use
Number of subjects: 130
Study 32400227 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher anger scores
Number of subjects: 130
Study 32400227 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater emotional support
Number of subjects: 130
Study 32400227 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological frailty
Number of subjects: 130
Study 32400227 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor family conflicts
Number of subjects: 130
Study 32400227 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher positive social interaction score
Number of subjects: 130
Study 36109420 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting First Relationships® (PFR) intervention
Number of subjects: 17
Study 33962602 — intervention group
Group type: EXPERIMENTAL
Intervention: MySmileBuddy Program (MSB Program)
Number of subjects: 858
Study 33962602 — intervention group
Group type: COMPARATOR
Intervention: Control Group (paper-based educational handout plus toothbrushes and fluoridated toothpaste for the child)
Number of subjects: 858
Study 32622294 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week Hatha yoga programme
Number of subjects: 114
Study 32622294 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 114
Study 32622294 — intervention group
Group type: COMPARATOR
Intervention: Both groups (yoga and control)
Number of subjects: 114
Study 35749253 — intervention group
Group type: EXPERIMENTAL
Intervention: Etelcalcetide plus active vitamin D (E+D group)
Number of subjects: 124
Study 35749253 — intervention group
Group type: EXPERIMENTAL
Intervention: Etelcalcetide plus oral calcium (E+Ca group)
Number of subjects: 124
Study 35749253 — intervention group
Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 124
Study 32024491 — intervention group
Group type: EXPERIMENTAL
Intervention: Model of Goal Directed Behavior (MGDB) scales
Number of subjects: 186
Study 35094139 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Waiting Room (IWR) with music and visual objects
Number of subjects: 104
Study 35094139 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Waiting Room (IWR)
Number of subjects: 104
Study 35094139 — intervention group
Group type: COMPARATOR
Intervention: Standard Waiting Room (StWR)
Number of subjects: 104
Study 34342134 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal spacer
Number of subjects: 20
Study 34342134 — intervention group
Group type: COMPARATOR
Intervention: No rectal spacer
Number of subjects: 20
Study 33883478 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (lifestyle modification program)
Number of subjects: 269
Study 33883478 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 269
Study 33883478 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 269
Study 33660429 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich Model with PRS
Number of subjects: 0
Study 33660429 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture (Control group)
Number of subjects: 0
Study 33660429 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich Model
Number of subjects: 0
Study 33660429 — intervention group
Group type: EXPERIMENTAL
Intervention: PRS incorporation
Number of subjects: 0
Study 33660429 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-PRS activities
Number of subjects: 0
Study 32185660 — intervention group
Group type: EXPERIMENTAL
Intervention: MAPS (Men and Providers Preventing Suicide) program
Number of subjects: 48
Study 32185660 — intervention group
Group type: COMPARATOR
Intervention: Control group (sleep hygiene video plus brief non-tailored text)
Number of subjects: 48
Study 32620259 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient blood management (PBM) interventions
Number of subjects: 54917
Study 33028693 — intervention group
Group type: EXPERIMENTAL
Intervention: APM score in NSCLC responders
Number of subjects: 51
Study 33028693 — intervention group
Group type: EXPERIMENTAL
Intervention: APM score above median in NSCLC
Number of subjects: 51
Study 33028693 — intervention group
Group type: EXPERIMENTAL
Intervention: APM score in NSCLC
Number of subjects: 51
Study 33028693 — intervention group
Group type: EXPERIMENTAL
Intervention: APM score in high-risk resectable stage III/IV melanoma patients
Number of subjects: 51
Study 33028693 — intervention group
Group type: EXPERIMENTAL
Intervention: APM score in metastatic melanoma patients
Number of subjects: 51
Study 36229113 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Experiments for Intolerance of Uncertainty (12 weekly 1-hour sessions)
Number of subjects: 60
Study 36229113 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 60
Study 32943241 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized oral nutritional supplement (S-ONS)
Number of subjects: 652